Literature DB >> 9300349

Pharmacokinetics of eltanolone following bolus injection and constant rate infusion.

K Parivar1, A Wessén, M Widman, A Nilsson.   

Abstract

Disposition of intravenous anaesthetic eltanolone was studied when administered as a bolus injection (B) of 0.75 mg/kg and constant rate intravenous infusion at 2 mg/kg/hr (12) and 3.5 mg/ kg/hr (13.5) for 2 hr in healthy male volunteers. Venous blood samples were collected for 12 hr and 20 hr following bolus injection and intravenous infusion, respectively. Serum eltanolone concentrations were determined by a specific gas chromatographic mass spectrometric assay. Using a nonlinear regression analysis, the individual data sets were best fitted by a three-compartment mamillary model with central elimination. Derived pharmacokinetic parameters expressed as median and 95% confidence intervals indicated an initial fast distribution with a half-life of 1.80 (0.23-5.47) min (B), 1.44 (0.97-2.06) min (12) and 1.44 (0.95-2.39) min (13.5), an intermediate phase with a half-life of 35.4 (28.7-45.2) min (B), 39.6 (31.0-47.9) min (12) and 35.4 (33.3-44.9) min (13.5) and a moderately short terminal phase with a half-life of 3.8 (2.7-5.9) hr (B), 5.0 (4.2-6.1) hr (12) and 4.6.(4.0-4.8) hr (13.5). The serum clearance after bolus injection was 1.37 (1.23-1.67) L/hr/kg and after infusion was 1.36 (1.25-1.52) L/hr/kg (12) and 1.17 (1.11-1.31) L/hr/kg (13.5). The pharmacokinetics of eltanolone appear to be linear over the dosage range studied. Pharmacokinetic parameters obtained after bolus injection were very much similar to the parameters obtained after infusion with the exception of t1/2 beta which was longer after the infusion (significant) and the volume of central compartment which was lower after infusion (not significant). Context sensitive times were estimated for a 30%, 50% and 80% drop in the concentration of eltanolone after different infusion times. A 30% drop in concentration is estimated to take about 2 to 3 min. A 50% drop in concentration is estimated to take about 8 min when duration of infusion is 3 hr and reaches a value of about 10 min by a duration of infusion of 10 hr. A 80% drop in concentration is estimated to take about 55 min following an infusion of 1 hr and it reaches a value of 70-80 min following an infusion of 10 hr.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9300349     DOI: 10.1007/BF02353479

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  13 in total

1.  Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs.

Authors:  M A Hughes; P S Glass; J R Jacobs
Journal:  Anesthesiology       Date:  1992-03       Impact factor: 7.892

2.  Concentration-effect relationships of eltanolone given as a bolus dose or constant rate intravenous infusion to healthy male volunteers.

Authors:  A Wessén; K Parivar; M Widman; A Nilsson; P Hartvig
Journal:  Anesthesiology       Date:  1996-06       Impact factor: 7.892

3.  Plasma clearance of fat emulsion in trauma and sepsis: use of a three-stage lipid clearance test.

Authors:  A P Robin; J Nordenström; J Askanazi; D H Elwyn; Y A Carpentier; J M Kinney
Journal:  JPEN J Parenter Enteral Nutr       Date:  1980 Sep-Oct       Impact factor: 4.016

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Relative potency of eltanolone, propofol, and thiopental for induction of anesthesia.

Authors:  J Van Hemelrijck; P Muller; H Van Aken; P F White
Journal:  Anesthesiology       Date:  1994-01       Impact factor: 7.892

6.  Preliminary study of a pregnanolone emulsion (Kabi 2213) for i.v. induction of general anaesthesia.

Authors:  H S Gray; B L Holt; D K Whitaker; P Eadsforth
Journal:  Br J Anaesth       Date:  1992-03       Impact factor: 9.166

7.  Effect of hypothermia and sampling site on blood esmolol concentrations.

Authors:  J R Jacobs; N D Croughwell; D K Goodman; W D White; J G Reves
Journal:  J Clin Pharmacol       Date:  1993-04       Impact factor: 3.126

8.  [Induction of anesthesia using the new intravenous steroid anesthetic eltanolone (pregnanolone). Dose determination and pharmacodynamics].

Authors:  W Hering; G Biburger; E Rügheimer
Journal:  Anaesthesist       Date:  1993-02       Impact factor: 1.041

9.  Disposition of propofol administered as constant rate intravenous infusions in humans.

Authors:  E Gepts; F Camu; I D Cockshott; E J Douglas
Journal:  Anesth Analg       Date:  1987-12       Impact factor: 5.108

10.  Pharmacokinetics and pharmacodynamics of eltanolone (pregnanolone), a new steroid intravenous anaesthetic, in humans.

Authors:  P Carl; S Høgskilde; T Lang-Jensen; V Bach; J Jacobsen; M B Sørensen; M Grälls; L Widlund
Journal:  Acta Anaesthesiol Scand       Date:  1994-10       Impact factor: 2.105

View more
  1 in total

1.  Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.

Authors:  H Ericsson; C Fakt; A Jolin-Mellgård; M Nordlander; L Sohtell; M Sunzel; C G Regårdh
Journal:  Br J Clin Pharmacol       Date:  1999-05       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.